Reaktionsgleichung
[CH:1]([C:4]1[C:5](=[O:21])[NH:6][C:7](=[O:20])[NH:8][C:9]=1[C:10](=[O:19])[C:11]1[CH:16]=[C:15]([CH3:17])[CH:14]=[C:13]([CH3:18])[CH:12]=1)([CH3:3])[CH3:2].[Si]([O:29][CH2:30][CH:31]1[CH:35]([CH2:36][O:37][Si](C(C)(C)C)(C)C)[CH2:34][C:33]([CH2:45]Br)=[CH:32]1)(C(C)(C)C)(C)C>>[OH:29][CH2:30][CH:31]1[CH:35]([CH2:36][OH:37])[CH2:34][C:33]([CH2:45][N:8]2[C:9]([C:10](=[O:19])[C:11]3[CH:12]=[C:13]([CH3:18])[CH:14]=[C:15]([CH3:17])[CH:16]=3)=[C:4]([CH:1]([CH3:3])[CH3:2])[C:5](=[O:21])[NH:6][C:7]2=[O:20])=[CH:32]1Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
5-Isopropyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione and [3,4-di(t-butyldimethylsilyloxymethyl)cyclopent-1-en-1-yl]methyl bromide were reacted by the same method with example 28 to obtain the titled compound (74 mg).
Quellen und Nachweise
- ORD-Eintrag
- ord-0876341c625343e3aca665566e713242
- Quelldatensatz
- uspto-grants-1999_07
- Patentnummer
- US05922727
Verknüpfte Notizen
Wird geladen…